152 related articles for article (PubMed ID: 29773172)
1. Seleno-l-methionine and l-ascorbic acid differentiate the biological activity of doxorubicin and its metal complexes as a new anticancer drugs candidate.
Matejczyk M; Świderski G; Świsłocka R; Rosochacki SJ; Lewandowski W
J Trace Elem Med Biol; 2018 Jul; 48():141-148. PubMed ID: 29773172
[TBL] [Abstract][Full Text] [Related]
2. Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2'-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism.
Qi YY; Gan Q; Liu YX; Xiong YH; Mao ZW; Le XY
Eur J Med Chem; 2018 Jun; 154():220-232. PubMed ID: 29803995
[TBL] [Abstract][Full Text] [Related]
3. Newly Synthesized Doxorubicin Complexes with Selected Metals-Synthesis, Structure and Anti-Breast Cancer Activity.
Jabłońska-Trypuć A; Świderski G; Krętowski R; Lewandowski W
Molecules; 2017 Jul; 22(7):. PubMed ID: 28677642
[TBL] [Abstract][Full Text] [Related]
4. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
[TBL] [Abstract][Full Text] [Related]
5. Some new nano-sized Fe(II), Cd(II) and Zn(II) Schiff base complexes as precursor for metal oxides: Sonochemical synthesis, characterization, DNA interaction, in vitro antimicrobial and anticancer activities.
Abdel-Rahman LH; Abu-Dief AM; El-Khatib RM; Abdel-Fatah SM
Bioorg Chem; 2016 Dec; 69():140-152. PubMed ID: 27816797
[TBL] [Abstract][Full Text] [Related]
6. Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1.
Bozorov K; Ma HR; Zhao JY; Zhao HQ; Chen H; Bobakulov K; Xin XL; Elmuradov B; Shakhidoyatov K; Aisa HA
Eur J Med Chem; 2014 Sep; 84():739-45. PubMed ID: 25064350
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of New Antibacterial Cubane-based Nanocomposite and its Application in Combination Cancer Therapy.
Zakerzadeh E; Salehi R; Mahkam M
Anticancer Agents Med Chem; 2018 Feb; 17(14):1898-1914. PubMed ID: 28530541
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
Gao M; Xu Y; Qiu L
J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line.
Bober P; Alexovic M; Talian I; Tomkova Z; Viscorova Z; Benckova M; Andrasina I; Ciccocioppo R; Petrovic D; Adamek M; Kruzliak P; Sabo J
J Cancer Res Clin Oncol; 2017 Jan; 143(1):35-42. PubMed ID: 27620743
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide.
Darwish S; Sadeghiani N; Fong S; Mozaffari S; Hamidi P; Withana T; Yang S; Tiwari RK; Parang K
Eur J Med Chem; 2019 Jan; 161():594-606. PubMed ID: 30396106
[TBL] [Abstract][Full Text] [Related]
12. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
[TBL] [Abstract][Full Text] [Related]
14. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
Banerjee S; Chakravarty AR
Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-loaded environmentally friendly carbon dots as a novel drug delivery system for nucleus targeted cancer therapy.
Yuan Y; Guo B; Hao L; Liu N; Lin Y; Guo W; Li X; Gu B
Colloids Surf B Biointerfaces; 2017 Nov; 159():349-359. PubMed ID: 28806666
[TBL] [Abstract][Full Text] [Related]
16. Examining the antimicrobial activity and toxicity to animal cells of different types of CO-releasing molecules.
Nobre LS; Jeremias H; Romão CC; Saraiva LM
Dalton Trans; 2016 Jan; 45(4):1455-66. PubMed ID: 26673556
[TBL] [Abstract][Full Text] [Related]
17. Silver(I) complexes of mono- and bidentate N-heterocyclic carbene ligands: synthesis, crystal structures, and in vitro antibacterial and anticancer studies.
Haque RA; Choo SY; Budagumpi S; Iqbal MA; Al-Ashraf Abdullah A
Eur J Med Chem; 2015 Jan; 90():82-92. PubMed ID: 25461313
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
Datir SR; Das M; Singh RP; Jain S
Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
[TBL] [Abstract][Full Text] [Related]
19. Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity.
Lu L; Liu LJ; Chao WC; Zhong HJ; Wang M; Chen XP; Lu JJ; Li RN; Ma DL; Leung CH
Sci Rep; 2015 Sep; 5():14544. PubMed ID: 26416333
[TBL] [Abstract][Full Text] [Related]
20. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]